99 related articles for article (PubMed ID: 34445837)
1. [Establishment and validation of prognosis predictive model using m
Xu JR; Yang DH; Long GF; Sun H; Chen HB
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Aug; 55(8):983-989. PubMed ID: 34445837
[No Abstract] [Full Text] [Related]
2. m
Liao X; Chen L; Liu J; Hu H; Hou D; You R; Wang X; Huang H
Epigenetics; 2023 Dec; 18(1):2160134. PubMed ID: 36567510
[TBL] [Abstract][Full Text] [Related]
3. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine reader IGF2BP3 promotes acute myeloid leukemia progression by controlling stabilization of EPOR mRNA.
Fan J; Zhuang M; Fan W; Hou M
PeerJ; 2023; 11():e15706. PubMed ID: 37663284
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and Validation of Immune Risk Score for Predicting Survival of Patients with Acute Myeloid Leukemia].
Hu F; Wang Y; Zhang Y; Zeng Y; Wang SQ; Pan XY; Yang TH; Liu QF; Liang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):327-333. PubMed ID: 35395958
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
8. m
Zhuang J; Lin C; Ye J
J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
[TBL] [Abstract][Full Text] [Related]
9. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
10. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
Shi M; Xu G
BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
Liu T; Li C; Jin L; Li C; Wang L
Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic model of methylation-associated genes in acute myeloid leukemia.
Chen M; Zeng Z; Qin W; Cai X; Lu X; Chen S
Clin Transl Oncol; 2023 Jun; 25(6):1719-1728. PubMed ID: 36715873
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a prognostic 8-gene signature for acute myeloid leukemia.
Zhang Y; Xiao L
Leuk Lymphoma; 2020 Aug; 61(8):1981-1988. PubMed ID: 32268820
[TBL] [Abstract][Full Text] [Related]
16. m
Hou J; Shan H; Zhang Y; Fan Y; Wu B
Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
[TBL] [Abstract][Full Text] [Related]
17. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
[TBL] [Abstract][Full Text] [Related]
18. Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia.
Wei J; Nai GY; Dai Y; Huang XJ; Xiong MY; Yao XY; Huang ZN; Li SN; Zhou WJ; Huang Y; Cheng P; Deng DH
Ann Transl Med; 2021 Sep; 9(17):1381. PubMed ID: 34733933
[TBL] [Abstract][Full Text] [Related]
19. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
20. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]